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Abstract
To examine effects of scan duration on estimates of regional rates of cerebral protein syn-
thesis (rCPS), we reanalyzed data from thirty-nine previously reported L-[1-11C]leucine PET
studies. Subjects consisted of 12 healthy volunteers studied twice, awake and under propo-
fol sedation, and 15 subjects with fragile X syndrome (FXS) studied once under propofol
sedation. All scans were acquired on a high resolution scanner. We used a basis function
method for voxelwise estimation of parameters of the kinetic model of L-[1-11C]leucine and
rCPS over the interval beginning at the time of tracer injection and ending 30, 45, 60, 75 or
90 min later. For each study and scan interval, regional estimates in nine regions and whole
brain were obtained by averaging voxelwise estimates over all voxels in the region. In all
three groups rCPS was only slightly affected by scan interval length and was very stable
between 60 and 90 min. Furthermore, statistical comparisons of rCPS between awake and
sedated healthy volunteers provided almost identical results when they were based on 60
min scan data as when they were based on data from the full 90 min interval. Statistical com-
parisons between sedated healthy volunteers and sedated subjects with FXS also yielded
almost identical results when based on 60 and 90 min scan intervals. We conclude that,
under the conditions of our studies, scan duration can be shortened to 60 min without loss of
precision.
Introduction
Fully quantitative measurement of regional rates of cerebral protein synthesis (rCPS) is now
possible with the L-[1-11C]leucine positron emission tomography (PET) method. The method
has been developed and validated for use in human subjects [1, 2]. The biological process of
protein synthesis is important to measure because it is an essential process for growth,
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maintenance and function of living organisms. This is especially true in the central nervous
system where de novo protein synthesis is involved in adaptive responses such as learning and
memory and neural plasticity. Moreover, animal studies indicate that rCPS are altered in mod-
els of various clinical disorders [3–7] and in certain physiologic states such as slow-wave sleep
[8]. rCPS also changes during brain development [9] and normal aging [10].
Measurements of rCPS in studies of awake age-matched healthy young men with the L-
[1-11C]leucine PET method are reproducible and have low variability [11]. rCPS are also unaf-
fected by propofol anesthesia in healthy young men [12]. This latter finding suggested that
subjects unable to tolerate the PET scanning procedures while awake, such as those with
neurodegenerative or neurodevelopmental disorders, could be studied under sedation. Such
studies must be undertaken with caution, however, as the sedative agent could have an effect
on rCPS in the patient group different from that seen in healthy controls [13]. An alternative
strategy to increase the likelihood that patients could tolerate scanning without sedation is to
reduce the total time required for scanning. Validation of the L-[1-11C]leucine PET method
was based on a 90 min scanning interval [2]. The scanning interval of 90 min was originally
chosen in order to allow sufficient time for most of the label in brain to be incorporated into
[11C]protein; this leads to greater accuracy in estimating rCPS. However, the half-life of 11C is
~20 min, and the increased noise due to low count rates at the end of the study may offset the
advantage of scanning for 90 min.
In the present study we examined the effects of shortened scan durations on estimates of
the parameters of the leucine kinetic model and on rCPS. We found that mean regional esti-
mates of the rate constants that act on the precursor pool of L-[1-11C]leucine in the tissue
decreased as the length of the scan interval increased. The estimated rate constant for transport
of leucine from plasma to tissue, and the estimated blood volume were only slightly altered by
changes in scan interval length. Most importantly, computed values of rCPS, quantitative mea-
surement of which is the goal of the PET scans, were very stable between 60 and 90 min.
Materials and methods
Data acquisition
Data from a previously-reported study of 12 healthy control subjects and 15 full mutation frag-
ile X subjects [13] were used for reanalysis in the current study. All subjects were male and 18–
24 yrs of age. Control subjects were studied once in the awake state, and on a separate day
again under propofol anesthesia. Fragile X subjects were studied only under propofol sedation.
The criteria for subject inclusion and the procedure for L-[1-11C]leucine PET studies have
been described previously [13]. Studies were performed on the ECAT High Resolution
Research Tomograph (HRRT) (CPS Innovations, Knoxville, TN), which has a spatial resolu-
tion of ~2.6 mm full width at half maximum (FWHM) [14]. A 90-min emission scan was initi-
ated coincident with a 2-min intravenous infusion of 27 ± 3 mCi (mean ± SD, n = 39; range
18–31 mCi) equivalent to 1.00 ± 0.11 GBq (mean ± SD, range 0.67–1.15 GBq) of L-[1-11C]leu-
cine (estimated specific activity 3 mCi/nmol (0.11 GBq/nmol)). Images were reconstructed by
means of the motion-compensated 3D ordinary Poisson ordered subset expectation maximi-
zation (OSEM) algorithm [14] as 42 frames of data (16x15, 4x30, 4x60, 4x150, 14x300 sec);
voxel size was 1.21x1.21x1.23 mm. Briefly, events are acquired on the HRRT in list-mode and
head-motion is measured during the scan with the Polaris system [15]. Individual events are
repositioned in space, and reconstruction is performed on the list-mode data by use of an
OSEM-type algorithm [16]. The expected value of the number of counts is determined
accounting for attenuation, normalization, randoms and scatter. Timed arterial blood samples
were drawn over the course of the scan, and concentrations of total 11C and 11CO2 in whole
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blood and labeled and unlabeled leucine concentrations in arterial plasma were measured as
described previously [11]. All subjects underwent a T1-weighted MRI of the brain for region
of interest (ROI) placement. This study was approved by the National Institutes of Health
Combined Neurosciences Institutional Review Board (06-M-0214, NCT00362843), the
National Institutes of Health Radioactive Drug Research Committee, and the National Insti-
tutes of Health Radiation Safety Committee. All subjects gave written informed consent.
Kinetic model
Fig 1 illustrates the homogeneous tissue kinetic model of the behavior of leucine in brain [1].
Based on the above kinetic model, total activity in the volume to be analyzed is given by
CTðtÞ ¼ ð1   VbÞ½C

EðtÞ þ P
ðtÞ þ VDC

CðtÞ þ VbC

bðtÞ: ð1Þ
Fig 1. Homogeneous tissue kinetic model for L-[1-11C]leucine. Total concentration of 11C (CT) includes free L-
[1-11C]leucine and L-[1-11C]leucine incorporated into tissue protein (CE and P, respectively), plus activity in blood
(VbCb, where Vb is the fraction of the volume occupied by blood and Cb is the concentration of activity in whole
blood). Total 11C also includes labeled products of L-[1-11C]leucine metabolism: 11CO2 and products of
11CO2
fixation. K1 and k2 are the rate constants for transport of leucine from plasma to tissue and back, respectively. k3 is the
rate constant for the first two steps in leucine catabolism, transamination and decarboxylation, which yield 11CO2. k4
and k5 are the rate constants for leucine incorporation into protein and release of free leucine from proteolysis,
respectively. It is assumed that (i) there is no significant breakdown of labeled product during the experimental
interval, i.e., k5P~0; (ii) fixation of 11CO2 during the experimental period is negligible [17, 18]; and (iii) equilibration
of diffusible 11CO2 between brain and blood is rapid [17]. The concentration of
11CO2 in tissue is approximated by
VDCc, where Cc is the 11CO2 concentration in whole blood and VD is the brain: blood equilibrium distribution
volume of 11CO2. VD was fixed at 0.41, the value measured in rhesus monkeys [2], which is in agreement with the
mean whole brain: plasma equilibrium distribution volume determined from 11CO2 studies in humans [19]. The
blood: plasma equilibrium distribution volume is close to unity [20]. The model assumes the tissue voxel is
homogeneous with respect to concentrations of amino acids, blood flow, rates of transport and metabolism of amino
acids, and rates of incorporation into protein [1]. The model used to describe labeled leucine also describes unlabeled
leucine (bottom row), except that unlabeled leucine and protein are in steady state, and the steady-state breakdown of
unlabeled protein (k5P) is greater than zero. Under the assumption that there is no isotope effect, the rate constants for
labeled and unlabeled leucine are identical.
https://doi.org/10.1371/journal.pone.0195580.g001
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Expressed in terms of rate constants we have
CT t; rð Þ ¼ 1   Vbð Þ
K1ðk2 þ k3Þ
k2 þ k3 þ k4
  Z t
0
CpðtÞe
  ðk2þk3þk4Þðt  tÞdtþ
K1k4
k2 þ k3 þ k4
  Z t
0
CpðtÞdtþ VDC

c tð Þ
 
þ VbC

b tð Þ ð2Þ
where Cp(τ) is the arterial plasma concentration of [11C]leucine. The dependence of total tis-
sue activity on the parameter vector ρ = [K1,k2+k3,k4,Vb] is now explicitly shown. Note that the
parameters k2 and k3 appear only as a sum in Eq (2); they cannot, therefore, be separately iden-
tified. Eq 2 is the model equation from which the rate constants and Vb were estimated.
For any given tissue rCPS can be calculated from the measured plasma concentration of
unlabeled leucine, Cp, and estimated values of the rate constants as [1]:
rCPS ¼
K1k4
k2 þ k3
 
Cp ð3Þ
Eq 3 accounts for recycling of unlabeled amino acids derived from tissue protein break-
down. It may be of interest to examine separately the effects of recycling. This can be done by
evaluating the factor λ, which represents the fraction of unlabeled leucine in the precursor
pool for protein synthesis that is derived from arterial plasma; the fraction derived from tissue
protein breakdown is (1-λ). Lambda can be computed from the rate constants of the kinetic
model as [1]:
l ¼
k2 þ k3
k2 þ k3 þ k4
ð4Þ
Rate constant estimation
Rate constants were estimated voxelwise by use of a basis function method (BFM) that utilizes
a grid search approach and linear least squares estimation [21]. In the case that any model
parameter estimate is negative (or if Vb is >1), estimates are replaced by those from the appro-
priately constrained linear least squares algorithm [22]. Under the conditions of our study, i.e.,
high resolution data and good counting statistics, BFM analysis based on the homogeneous tis-
sue model can be used for estimation of rCPS at the voxel level, as the impact on rCPS of
kinetic heterogeneity present in some voxels in the tissue is negligible [22, 23]. The BFM grid
consists of a set of values for β = k2+k3+k4 in the physiological range. For our dataset, 100 val-
ues equally spaced between βmin = 0.0001 min
-1 and βmax = 0.5 min
-1 were used. Weights were
inversely proportional to variance in whole brain activity, which was modeled assuming Pois-
son statistics, as [24]
Var CTðtiÞ
 
¼ as2i ¼ a
expðgtiÞCTðtiÞ
Dti
ð5Þ
where γ is the decay constant for 11C, Δti is the length of Frame i, CT(ti) is the mean decay-cor-
rected concentration of 11C in whole brain in Frame i, and α is a proportionality coefficient
reflecting the noise level in the data. In PET data, α is not known a priori, but its value does not
affect parameter estimates; for the parameter estimation process its value is set to one.
The difference between tracer arrival time in brain and arterial sampling site was estimated
by shifting blood curves 0–30 sec, fitting the whole brain time-activity curve (from time of
injection to end of scan interval under consideration), and selecting the delay that produced
the smallest weighted residual sum of squares. Tracer appearance times in various parts of the
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brain differ from the mean of the brain as a whole by ±2 sec [25]; therefore whole brain tracer
arrival delay was used for all voxels. The whole brain is very kinetically heterogeneous, not
only exhibiting differences in kinetics between gray and white matter, but also within gray
matter itself. Therefore, for estimating the tracer arrival delay, whole brain time-activity curves
were fitted by a spectral analysis method that allows for heterogeneity within the tissue ROI
[26].
Parameter estimation was performed on PET data resliced to match the subject’s MRI.
Voxel size was [0.84–0.95 mm]3, except in one healthy volunteer whose MRI voxel size was [1
mm]3. Results are presented in terms of parameter values averaged over all voxels within a pre-
defined ROI.
Region of interest identification
ROIs were manually outlined on each subject’s MRI by visually identifying anatomic land-
marks. A binary mask was constructed to identify voxels in the region. Nine ROIs and whole
brain were analyzed for each subject.
To coregister MRI and PET images, a three-dimensional volume was constructed from the
average of the emission data acquired between 30 and 60 min. This volume was isotropically
smoothed with a Gaussian filter (FWHM 3 mm) and aligned to the MRI volume by means
of the Flexible Image Registration Toolbox [27] with a 3D rigid body transformation. The
resliced average 30 to 60 min PET image was visually reviewed for correct alignment with the
MRI by use of Vinci software (Volume Imaging in Neurological Research, Max-Planck-Insti-
tute for Neurological Research, Cologne, Germany). The transformation parameters were then
applied to each frame of the PET study (without prior smoothing) to effect their alignment
with the MRI volume. After the PET data had been resliced to match the MRI, BFM was
applied to estimate kinetic model parameters, λ, and rCPS for each voxel within the brain; esti-
mation intervals of 0–30, 0–45, 0–60, 0–75, and 0–90 min were used. Mean parameter esti-
mates for each ROI and each estimation interval were then computed by applying the binary
ROI mask to the volumes representing voxelwise estimates of K1, k2+k3, k4, Vb, λ, and rCPS.
We also examined the intervoxel variability of rCPS within a region (for each region, subject,
and estimation interval), by computing the coefficient of variation of the individual voxel esti-
mates of rCPS within the ROI.
Statistical analyses
We tested for effects of scan duration on rCPS by means of repeated measures (RM) ANOVA
with RM on both regions and scan duration. Each group/condition was examined separately.
In the case of a statistically significant interaction we further probed for differences by means
of paired t-tests with the 90 minute value as the “control” and Dunnett’s correction for multi-
ple comparisons.
We tested for differences in rCPS between healthy controls awake and sedated at 60 and 90
min scan durations by means of RM ANOVA (region and condition as within subjects vari-
ables). We tested for differences in rCPS between sedated healthy controls and sedated fragile
subjects at 60 and 90 min scan durations by means of RM ANOVA (region as within subjects
variable and diagnosis as between subjects variable). In the case of a statistically significant
interaction we further probed for effects of diagnosis by means of two-tailed t-tests. Scan dura-
tions (60 and 90 min) were analyzed separately. We used SPSS, Version 21 (IBM, Armonk,
NY, USA) for all statistical analyses.
Shortened PET scanning intervals for rCPS determination with L-[1-11C]leucine
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Results
Regional estimates of kinetic model parameters and λ
Regional estimates of the kinetic model parameters and λ (means ± intersubject standard devi-
ations (SD)) for each of the three groups are shown graphically in S1–S5 Figs. Parameters were
estimated for each voxel over a 30, 45, 60, 75, or 90 min interval; for each study and interval,
parameter estimates and λ were then averaged over all voxels in whole brain and in nine
regions. Parameter estimates showed changes with increasing scan duration that were similar
in all three groups, both in direction and magnitude. Estimates of K1 (S1 Fig) decreased slightly
with increasing scan times; between the 60 and 90 min scan durations mean regional estimates
decreased 3–5%. Decreases in estimates of k2+k3 (S2 Fig) and k4 (S3 Fig) were more substan-
tial; between the 60 and 90 min scan durations regional estimates decreased 6–15% and 7–17%
for k2+k3 and k4, respectively. Estimates of Vb (S4 Fig) increased 3–7% between 60 and 90 min.
Changes in λ (S5 Fig) with increasing estimation interval were smaller than those in individual
rate constants; the mean of the percentage decrease in λ was 1–3% (depending on the region)
between the 60 and 90 min estimation intervals. Decreases in the estimates of k2+k3 and k4
with increasing estimation interval are consistent with the presence of kinetic heterogeneity in
at least some voxels in the regions [22, 23, 28, 29].
Regional estimates of rCPS
Regional mean estimates of rCPS for the three groups are shown in Fig 2. Differences in
regional mean rCPS values over the different estimation intervals were small. The change in
the mean rCPS between 60 and 90 min ranged from -3% to +2% in the awake healthy control
group, from -2% to +2% in the sedated healthy control group, and from -1% to +2% in the
sedated fragile X group.
The empirical cumulative distributions of individual voxel values of rCPS in all brain voxels
for each estimation interval are shown in Fig 3. Distributions are from studies of a single
healthy control subject scanned awake and under propofol anesthesia. The data show that
there are more brain voxels with rCPS not detectably different from zero when the 30 and 45
min intervals are used for estimation. There are also relatively fewer voxels with high values of
rCPS with the shorter estimation intervals, most notably with the 30 min interval. The distri-
butions of rCPS estimated on the 60, 75, and 90 min intervals were very similar except for
small differences in low rCPS values. The differences in low rCPS values were slightly greater
when the subject was studied under sedation.
Regional values of rCPS in whole brain and nine ROIs for all three subject groups are
shown in Table 1. Values were computed from PET data with scanning durations of 60 and 90
min. Means and SDs of rCPS computed for these two scanning intervals are almost identical.
The mean relative difference in rCPS did not exceed 2% in magnitude in any region or group,
except in the hippocampus (Awake Control Group) and amygdala (Fragile X sedated group)
where it reached 3%. In the healthy control group we compared rCPS in the awake studies
with the propofol-sedated studies for each scan duration. Neither the interaction between
region and condition nor the main effect of condition was statistically significant at either scan
duration indicating no effect of propofol sedation on rCPS in any region.
We also compared rCPS in the propofol-sedated controls with the propofol-sedated fragile
X subjects (Table 1). With either a 60 min or 90 min scan duration results were similar. The
interaction between region and diagnosis was statistically significant at both 60 and 90 min
scan durations. We further probed for statistically significant differences in specific regions by
means of post-hoc two-tailed t-tests. Results were the same at both 60 and 90 min scan
Shortened PET scanning intervals for rCPS determination with L-[1-11C]leucine
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Fig 2. rCPS estimated over the interval beginning at the time of injection and ending 30, 45, 60, 75, or 90 min
later. The Basis Function Method was used to estimate the rate constants of the homogeneous tissue kinetic model,
rCPS was computed for each voxel in the brain, and ROI values were obtained by averaging values over all voxels in the
ROI. The following regions were evaluated: whole brain (WB), cerebellum (Ce), frontal cortex (FCx), parietal cortex
(PCx), thalamus (Thal), caudate (Cau), putamen (Pu), amygdala (Amyg), and hippocampus (Hi). Points represent
means ± SD for 12 healthy control subjects studied awake, 12 healthy control subjects studied sedated, and 15 FrX
subjects studied sedated. Estimates of each parameter were analyzed for statistically significant effects by means of RM
ANOVA with region and scan duration as within subjects variables. Awake healthy control group: Interaction
between region and scan duration was statistically significant (F7.9,87.2 = 3.82, P = 0.001). Post-hoc paired comparisons
between the estimates at a 90 min scan duration with all other scan durations for each region are indicated on the
figure. , P 0.05; , P 0.01. Propofol-sedated healthy control group: Interaction between region and scan
duration was statistically significant (F6.3,69.0 = 2.37, P = 0.036). Post-hoc paired comparisons between the estimates at a
90 min scan duration with all other scan durations for each region are indicated on the figure. , P 0.05; , P 0.01.
Propofol-sedated subjects with FXS: Interaction between region and scan duration was statistically significant
(F9.3,130.6 = 4.78, P<0.001). Post-hoc paired comparisons between the estimates at a 90 min scan duration with all other
scan durations for each region are indicated on the figure. , P 0.05; , P 0.01.
https://doi.org/10.1371/journal.pone.0195580.g002
Shortened PET scanning intervals for rCPS determination with L-[1-11C]leucine
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durations. In the sedated fragile X subjects rCPS was lower compared with the sedated healthy
controls in the brain as a whole, cerebellum and frontal and parietal cortices (P< 0.05). Differ-
ences between healthy controls and fragile X subjects ranged from 8 to 12% regardless of the
scan duration.
Regional intervoxel variability of rCPS
In every subject, the intervoxel variability of rCPS within each region was observed to decrease
with increasing length of the estimation interval. In whole brain the mean coefficients of varia-
tion in the awake group of control subjects were 56%, 52%, and 49% for the 60, 75, and 90 min
scanning intervals, respectively. The thalamus generally had the lowest intervoxel variability
(40%, 37%, and 35%) and the amygdala the highest (68%, 60%, and 54%). Interestingly, the
cortical regions exhibited lower intervoxel variability than white matter (frontal cortex: 45%,
40%, and 38%; corona radiata: 64%, 54%, and 49% for the 60, 75, and 90 min scanning inter-
vals, respectively). The other two groups of subjects showed similar results. Parametric maps
Fig 3. Cumulative probability distribution of rCPS. The ordinate is the fraction of the total brain voxels at each of
the rCPS levels shown on the abscissa. Data are from 1.9x106 voxels in the brain of a healthy 23 year old male studied
awake and under propofol sedation. Values of rCPS were estimated on an interval of 30 min (red), 45 min (yellow), 60
min (green), 75 min (magenta), and 90 min (blue). rCPS was computed for each voxel in the brain from the rate
constants of the homogeneous tissue kinetic model estimated with the Basis Function Method.
https://doi.org/10.1371/journal.pone.0195580.g003
Shortened PET scanning intervals for rCPS determination with L-[1-11C]leucine
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Table 1. Regional rates of cerebral protein synthesis (nmol/g/min).
60 min
Region Healthy
volunteers
conscious
Healthy
volunteers
sedated
Fragile X
Subjects
sedated
P-value
Whole Brain 1.70 ± 0.14 1.68 ± 0.12 1.51 ± 0.12 0.001
Cerebellum 1.96 ± 0.17 1.95 ± 0.15 1.79 ± 0.15 0.009
Cortex
Parietal 2.05 ± 0.23 2.01 ± 0.14 1.80 ± 0.17 0.002
Frontal 2.06 ± 0.21 2.08 ± 0.15 1.83 ± 0.16 0.001
Subcortical
Caudate 1.09 ± 0.11 1.12 ± 0.17 1.07 ± 0.12 0.340
Putamen 1.38 ± 0.13 1.43 ± 0.23 1.28 ± 0.15 0.052
Thalamus 1.73 ± 0.15 1.66 ± 0.17 1.69 ± 0.16 0.637
Hippocampus 1.53 ± 0.14 1.59 ± 0.17 1.53 ± 0.17 0.355
Amygdala 1.44 ± 0.17 1.46 ± 0.22 1.43 ± 0.20 0.741
White Matter
Corona radiata 0.81 ± 0.09 0.83 ± 0.12 0.76 ± 0.07 0.065
90 min
Region Healthy
volunteers
conscious
Healthy
volunteers
sedated
Fragile X
Subjects
sedated
P-value
Whole Brain 1.68 ± 0.15 1.67 ± 0.11 1.52 ± 0.12 0.002
Cerebellum 1.93 ± 0.18 1.95 ± 0.16 1.79 ± 0.15 0.014
Cortex
Parietal 2.02 ± 0.24 2.01 ± 0.14 1.82 ± 0.17 0.005
Frontal 2.04 ± 0.22 2.07 ± 0.14 1.86 ± 0.16 0.002
Subcortical
Caudate 1.09 ± 0.11 1.13 ± 0.13 1.09 ± 0.11 0.462
Putamen 1.38 ± 0.16 1.43 ± 0.19 1.31 ± 0.13 0.055
Thalamus 1.70 ± 0.16 1.65 ± 0.16 1.68 ± 0.14 0.621
Hippocampus 1.48 ± 0.13 1.55 ± 0.18 1.56 ± 0.14 0.923
Amygdala 1.42 ± 0.22 1.49 ± 0.29 1.45 ± 0.20 0.697
White Matter
Corona radiata 0.83 ± 0.08 0.81 ± 0.08 0.75 ± 0.09 0.068
Rate constants were estimated voxelwise by use of the basis function method of Tomasi et al [21]. Values of regional rates of cerebral protein synthesis are the
means ± SD for 12 healthy volunteers and 15 fragile X subjects, except in hippocampus and amygdala. In one healthy volunteer the quality of the MRI was poor, and we
were unable to decipher the edges of these two regions; therefore, in hippocampus and amygdala data are from 11 Healthy volunteers and 15 fragile X subjects.
In the comparison of states (awake, sedated) in healthy controls at 60 min or 90 min scan durations, neither the interaction (RM ANOVA) between region and state
(F5.5,60.6 = 1.81, P = 0.118 and F5.0,54.8 = 2.06, P = 0.085, respectively) nor the main effect of state (F1,60.6 = 0.02, P = 0.903 and F1,54.8 = 0.136, P = 0.720, respectively) was
statistically significant, but the main effect of region was (F5.5,60.6 = 285, P<0.001 and F5.0,54.8 = 272, P<0.001, respectively). In the comparison of sedated healthy
controls and fragile X subjects the interaction (RM ANOVA) between region and state was statistically significant for both the 60 min and 90 min scan durations
(F4.5,112 = 4.70, P = 0.001 and F4.7, 116 = 5.89, P<0.001, respectively). Results of post-hoc comparisons by means of two-tailed t-tests comparing sedated fragile X subjects
with sedated healthy volunteers are indicated in the table;
P0.05;
P0.01;
P0.005.
https://doi.org/10.1371/journal.pone.0195580.t001
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of rCPS estimated on the scan intervals between 30 and 90 min in a transverse plane through
the frontal cortex are shown in Fig 4.
Discussion
Our study shows that under the conditions of high spatial resolution and voxelwise data analy-
sis with a homogeneous tissue model, decreasing the scan duration of L-[1-11C]leucine PET
studies from 90 to 60 min has negligible effects on estimates of rCPS.
The L-[1-11C]leucine PET method was developed and validated to make possible fully
quantitative measurements of rCPS in human subjects [1, 2]. In order to determine rCPS, the
method requires estimates of the parameters of a kinetic model that describes the time courses
of [11C]leucine and [11C]protein in brain, estimates that must be made from PET measure-
ments of total radioactivity. Immediately after tracer injection, almost all activity in brain is in
the form of [11C]leucine. Free [11C]leucine in brain increases for about 5–8 min after tracer
injection and then begins to clear, reaching a level of approximately 10–20% of the total activ-
ity by 90 min. The amount of [11C]protein, on the other hand, increases throughout the study
and reaches a level of about 80–90% of the total activity by 90 min after injection. Having a
scan interval that includes a period with substantial efflux of tracer from brain (early in the
study) as well as a period with substantial incorporation of label into product (late in the
study) enhances our ability to obtain good estimates for the kinetic model rate constants that
describe these processes, and hence obtain good estimates of rCPS. While a longer tracer circu-
lation period would, at least in theory, further improve the estimates of the kinetic model
parameters and rCPS, the period cannot be extended indefinitely. Firstly, the kinetic model
assumes that there is only negligible breakdown of labeled protein during the study, but
Fig 4. Parametric images of rates of cerebral protein synthesis (rCPS). Data from a L-[1-11C]leucine PET study of a
healthy awake 22 year old male subject. Kinetic model parameters of the homogeneous tissue kinetic model and rCPS
were estimated with the Basis Function Method over the intervals 0–30, 0–45, 0–60, 0–75, and 0–90 min. A Gaussian
filter (2.0 mm FWHM kernel) was employed to smooth the parametric images in three dimensions before visualization.
The MRI Image to which the PET images were coregistered is shown at the upper left. All images are in transverse plane
on which the frontal cortex has been outlined.
https://doi.org/10.1371/journal.pone.0195580.g004
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eventually loss of labeled product would become significant. Secondly, 11C has a half-life of
~20 mins and noise due to low count rates increases significantly at later times. Finally, longer
scanning times increase the discomfort for the subject who must lie as motionless as possible
on the scanner bed throughout the study, and limit the number of studies that can be com-
pleted on a single scanner.
Whereas it was impractical to lengthen the scanning interval beyond 90 min, we asked
whether the scan could be shortened without losing accuracy in determinations of rCPS.
Shorter scanning times would be of obvious benefit to subjects, and might even make it possi-
ble to scan patients who cannot tolerate longer scanning intervals without sedation. We have
now acquired a large database of L-[1-11C]leucine studies in which PET data were acquired
over a 90 min interval. This allowed us the opportunity to investigate what would have been
the results had we used a shorter scanning time.
In the present study we firstly examined the effects of shortened scan durations on esti-
mates of the parameters of the leucine homogeneous tissue kinetic model and on rCPS by
reanalyzing data from thirty-nine previously acquired PET studies. Data were analyzed over
scanning intervals of 30, 45, 60, 75, and 90 min. Estimates of the kinetic model rate constants
k2+k3 (for efflux from brain plus metabolism of [11C]leucine) and k4 (for incorporation
of leucine into protein) were found to decrease as the length of the scanning interval
increased, consistent with tissue heterogeneity in at least some voxels within each region
[29]. Decreases were, however, of similar magnitude for both k2+k3 and k4 and their ratio,
which appears in the computation of rCPS, was fairly constant. Estimates of K1 also
decreased slightly with increasing estimation interval; this is likely due to tradeoffs made in
the estimation algorithm between increases in K1 and decreases in k2+k3. Despite changes in
estimates of individual rate constants, rCPS was substantially unchanged for estimation
intervals between 60 and 90 min.
We did note a slightly smaller intervoxel variability in rCPS with increasing estimation
interval. We do not know, however, if this reflects more accurate voxel estimations due to the
use of the extended time course of PET data, or alternatively, if the high noise levels of the late
time data actually decrease our ability to differentiate true variations in rCPS that exist at dif-
ferent voxel locations.
We also found that the small differences in rCPS estimated at the various scanning intervals
did not alter results of the statistical comparisons between our subject condition/group. At a
scanning interval of 60 min, the same regions found to be statistically significantly different
between groups and even p-values were remarkably consistent. Thus, in all respects, we obtain
the same results regardless of the analysis interval chosen.
We conclude that under the conditions of our study, i.e., high resolution voxel level data
analyzed with a homogeneous tissue kinetic model, the scanning time for a L-[1-11C]leucine
PET study can be reduced from 90 to 60 min without loss of precision.
Supporting information
S1 Dataset. Individual values for the estimated parameters and rCPS.
(XLSX)
S1 Fig. K1, the rate constant for transport of leucine from plasma to tissue, estimated over
the interval beginning at the time of injection and ending 30, 45, 60, 75, or 90 min later.
The Basis Function Method, based on the homogeneous tissue kinetic model for L-[1-11C]leu-
cine, was used to estimate K1 for each voxel in the brain, and ROI values were obtained by
averaging estimates over all voxels in the ROI. The following regions were evaluated: whole
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brain (WB), cerebellum (Ce), frontal cortex (FCx), parietal cortex (PCx), thalamus (Thal),
caudate (Cau), putamen (Pu), amygdala (Amyg), and hippocampus (Hi). Points represent
means ± SD for 12 healthy control subjects studied awake, 12 healthy control subjects studied
sedated, and 15 FrX subjects studied sedated.
(TIF)
S2 Fig. k2+k3, the rate constant for transport of leucine from tissue to plasma plus the rate
constant for the first two steps in leucine catabolism, estimated over the interval beginning
at the time of injection and ending 30, 45, 60, 75, or 90 min later. The Basis Function
Method, based on the homogeneous tissue kinetic model for L-[1-11C]leucine, was used to
estimate k2+k3 for each voxel in the brain, and ROI values were obtained by averaging esti-
mates over all voxels in the ROI. The following regions were evaluated: whole brain (WB), cer-
ebellum (Ce), frontal cortex (FCx), parietal cortex (PCx), thalamus (Thal), caudate (Cau),
putamen (Pu), amygdala (Amyg), and hippocampus (Hi). Points represent means ± SD for 12
healthy control subjects studied awake, 12 healthy control subjects studied sedated, and 15 FrX
subjects studied sedated.
(TIF)
S3 Fig. k4, the rate constant for leucine incorporation into protein, estimated over the
interval beginning at the time of injection and ending 30, 45, 60, 75, or 90 min later. The
Basis Function Method, based on the homogeneous tissue kinetic model for L-[1-11C]leucine,
was used to estimate k4 for each voxel in the brain, and ROI values were obtained by averaging
estimates over all voxels in the ROI. The following regions were evaluated: whole brain (WB),
cerebellum (Ce), frontal cortex (FCx), parietal cortex (PCx), thalamus (Thal), caudate (Cau),
putamen (Pu), amygdala (Amyg), and hippocampus (Hi). Points represent means ± SD for 12
healthy control subjects studied awake, 12 healthy control subjects studied sedated, and 15 FrX
subjects studied sedated.
(TIF)
S4 Fig. Vb, the fraction of blood in the tissue, estimated over the interval beginning at the
time of injection and ending 30, 45, 60, 75, or 90 min later. The Basis Function Method,
based on the homogeneous tissue kinetic model for L-[1-11C]leucine, was used to estimate Vb
for each voxel in the brain, and ROI values were obtained by averaging estimates over all voxels
in the ROI. The following regions were evaluated: whole brain (WB), cerebellum (Ce), frontal
cortex (FCx), parietal cortex (PCx), thalamus (Thal), caudate (Cau), putamen (Pu), amygdala
(Amyg), and hippocampus (Hi). Points represent means ± SD for 12 healthy control subjects
studied awake, 12 healthy control subjects studied sedated, and 15 FrX subjects studied
sedated.
(TIF)
S5 Fig. λ, the fraction of unlabeled leucine in the precursor pool for protein synthesis that
is derived from arterial plasma, estimated over the interval beginning at the time of injec-
tion and ending 30, 45, 60, 75, or 90 min later. Based on parameter estimates of k2+k3 and k4,
λ was computed for each voxel in the brain, and ROI values were obtained by averaging values
over all voxels in the ROI. The following regions were evaluated: whole brain (WB), cerebel-
lum (Ce), frontal cortex (FCx), parietal cortex (PCx), thalamus (Thal), caudate (Cau), putamen
(Pu), amygdala (Amyg), and hippocampus (Hi). Points represent means ± SD for 12 healthy
control subjects studied awake, 12 healthy control subjects studied sedated, and 15 FrX sub-
jects studied sedated.
(TIF)
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